Actively Recruiting
Evaluating Vein Stenting Plus Medication for Adults with Idiopathic Intracranial Hypertension Not Fully Controlled by Long-term Acetazolamide
Led by University Hospital, Montpellier · Updated on 2026-03-06
114
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating idiopathic intracranial hypertension IIH, a condition marked by increased pressure in the brain causing symptoms like visual loss, chronic headache, and tinnitus. The study focuses on patients who have been treated with acetazolamide for more than one year but continue to have symptoms or intolerable side effects. The goal is to determine if placing a stent in a specific brain vein, called the transverse sinus, can reduce this pressure and improve symptoms compared to standard medical care alone. Participants will be randomly assigned to one of two groups. One group will receive best medical care, which includes acetazolamide and recommended weight loss. The other group will receive the same medical care plus a stent placed in the transverse sinus vein through a neuroradiological procedure. The study includes follow-up visits at 1, 3, and 12 months to assess outcomes. During the study, participants will undergo evaluations including intracranial pressure measurement, headache frequency and severity, tinnitus, visual acuity and field, papilledema optic swelling, and cognitive and autonomy assessments. Researchers will monitor how many patients achieve normalized intracranial pressure after three months. The study aims to provide detailed data on symptom changes and medication discontinuation, with a total participation period of at least one year.
CONDITIONS
Brief Title
Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide
Research Team
V
Vincent COSTALAT, MD, PhD
F
Fédérico CAGNAZZO, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here